RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,566,000 | -2.2% | 99,523 | 0.0% | 0.05% | +2.0% |
| Q4 2019 | $4,671,000 | -83.9% | 99,523 | -91.9% | 0.05% | -87.0% |
| Q3 2019 | $29,042,000 | -17.7% | 1,228,000 | +4.2% | 0.38% | -12.5% |
| Q2 2019 | $35,267,000 | +53.7% | 1,178,000 | +15.0% | 0.44% | +50.2% |
| Q1 2019 | $22,939,000 | +43.4% | 1,024,000 | +16.5% | 0.29% | +19.1% |
| Q4 2018 | $15,997,000 | +103.3% | 879,000 | +102.1% | 0.25% | +134.3% |
| Q3 2018 | $7,869,000 | +427.1% | 435,000 | +190.0% | 0.10% | +337.5% |
| Q2 2018 | $1,493,000 | +86.2% | 150,000 | -0.7% | 0.02% | +71.4% |
| Q1 2018 | $802,000 | -37.5% | 151,000 | 0.0% | 0.01% | -36.4% |
| Q4 2017 | $1,284,000 | -24.2% | 151,000 | +30.2% | 0.02% | -26.7% |
| Q3 2017 | $1,694,000 | +11.6% | 116,000 | +43.2% | 0.03% | +3.4% |
| Q2 2017 | $1,518,000 | – | 81,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|